載入...
Targeting a neoantigen derived from a common TP53 mutation
TP53 (tumor protein p53) is the most commonly mutated cancer driver gene, but drugs that target mutant tumor suppressor genes, such as TP53, are not yet available. Here, we describe the identification of an antibody highly specific to the most common TP53 mutation (R175H, in which arginine at positi...
Na minha lista:
| 發表在: | Science |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208645/ https://ncbi.nlm.nih.gov/pubmed/33649166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.abc8697 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|